Based on the earlier demonstration that GSDMD activation in CD4+ T cells is critical for antitumor immunity in animal models, we further examined the correlation between tumor prognosis and GSDMD activation levels in tumor-infiltrating CD4+ T cells by conducting tissue microarray–based immunofluorescence in a single-center retrospective cohort study. The gene discussed is CD4; the disease is neoplasm.